$10M for Tetraphase
Wade Roush9/25/09
Watertown, MA-based Tetraphase Pharmaceuticals has raised $10 million out of a planned $29.6 million equity financing round, according to regulatory documents filed Wednesday. The Harvard spinoff, which is using synthetic chemistry to develop new antibiotics for drug-resistant infections, previously raised $25 million in two tranches that closed in August 2008.
Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can e-mail him at wroush@xconomy.com or follow him on Twitter at twitter.com/wroush.
Daily Digest for September 26th « BostonDave
9/26/09 9:15 pm
[...] Shared $10M for Tetraphase [...]
David’s Weekly Tech Reader - 93South – Thoughts on New England Web 2.0
9/27/09 9:45 pm
[...] $10M for TetraphasePublished: September 25, 2009Source: Xconomy [...]